Can Sodium Thiosulfate Act as a Reversal Agent for Calcium Hydroxylapatite Filler? Results of a Preclinical Study

Wojciech Danysz,1 Bartosch Nowag,1 Thomas Hengl,1 Peter Kreymerman,2 Céline Furne,3 Elise Madeuf,4 Christoph Höennscheidt,1 Deanne Mraz Robinson5,6 1R&D, Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany; 2Medical Affairs, Merz North America, Raleigh, NC, USA; 3NAMSA,...

Full description

Bibliographic Details
Main Authors: Danysz W, Nowag B, Hengl T, Kreymerman P, Furne C, Madeuf E, Höennscheidt C, Mraz Robinson D
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:Clinical, Cosmetic and Investigational Dermatology
Subjects:
Online Access:https://www.dovepress.com/can-sodium-thiosulfate-act-as-a-reversal-agent-for-calcium-hydroxylapa-peer-reviewed-article-CCID
id doaj-d7ada739b95b4fa989d95573cf6f4650
record_format Article
spelling doaj-d7ada739b95b4fa989d95573cf6f46502021-01-06T01:27:12ZengDove Medical PressClinical, Cosmetic and Investigational Dermatology1178-70152020-12-01Volume 131059107360789Can Sodium Thiosulfate Act as a Reversal Agent for Calcium Hydroxylapatite Filler? Results of a Preclinical StudyDanysz WNowag BHengl TKreymerman PFurne CMadeuf EHöennscheidt CMraz Robinson DWojciech Danysz,1 Bartosch Nowag,1 Thomas Hengl,1 Peter Kreymerman,2 Céline Furne,3 Elise Madeuf,4 Christoph Höennscheidt,1 Deanne Mraz Robinson5,6 1R&D, Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany; 2Medical Affairs, Merz North America, Raleigh, NC, USA; 3NAMSA, Chasse sur Rhône, France; 4Preclinical Studies, Voxcan, Marcy L´Etoile, France; 5Modern Dermatology of Connecticut, Westport, CT, USA; 6Yale-New Haven Hospital, New Haven, CT, USACorrespondence: Wojciech DanyszMerz Pharmaceuticals GmbH, Eckenheimer Landstrasse 100, Frankfurt am Main 60318, GermanyEmail Wojciech.danysz@merz.deIntroduction: Calcium hydroxylapatite microspheres suspended in a gel carrier of sodium carboxymethylcellulose (CaHA; Radiesse®) has demonstrated safe and effective restoration of facial volume in clinical trials, as well as collagen biostimulation leading to skin quality improvement. The potential with CaHA, as with any filler, to produce overcorrection and subsequent complications has led to the search for a reversal agent. Sodium thiosulfate (STS) was proposed based on experience with it as a chelating agent to treat calciphylaxis. Previous pilot studies with small sample sizes have suggested its efficacy in the reduction of CaHA volume and nodule formation. The present study focuses on the verification of this effect using various readout methods in preclinical experiments.Methods: We use both in vitro (co-incubation of STS with CaHA) and in vivo (injections in farm pig) methods with readout techniques such as 3D camera analysis, micro-computed tomography ex vivo (μCT), computed tomography in vivo (CT), histopathology and scanning electron microscopy.Results: We did not obtain any indications of CaHA degradation by STS, either in vitro or in vivo. 3D-camera analysis also did not show any decreasing effect of STS on CaHA. However, histology, μCT ex vivo, and CT in vivo indicated a decrease of Radiesse amount/volume after STS treatment, which could be attributed to dispersion effect. It should be noted that necrosis and haemorrhages were observed after STS treatment.Discussion: Results suggest no indication of CaHA microspheres degradation with STS and that the STS mechanism of action on CaHA is consistent with a dispersion effect. Observed necrosis is a further obstacle in the use of STS.Keywords: calcium hydroxylapatite, sodium thiosulfate, dispersion effect, computed tomography, histology, 3D camerahttps://www.dovepress.com/can-sodium-thiosulfate-act-as-a-reversal-agent-for-calcium-hydroxylapa-peer-reviewed-article-CCIDcalcium hydroxylapatitesodium thiosulfatedispersion effectcomputer tomographyhistology3d camera
collection DOAJ
language English
format Article
sources DOAJ
author Danysz W
Nowag B
Hengl T
Kreymerman P
Furne C
Madeuf E
Höennscheidt C
Mraz Robinson D
spellingShingle Danysz W
Nowag B
Hengl T
Kreymerman P
Furne C
Madeuf E
Höennscheidt C
Mraz Robinson D
Can Sodium Thiosulfate Act as a Reversal Agent for Calcium Hydroxylapatite Filler? Results of a Preclinical Study
Clinical, Cosmetic and Investigational Dermatology
calcium hydroxylapatite
sodium thiosulfate
dispersion effect
computer tomography
histology
3d camera
author_facet Danysz W
Nowag B
Hengl T
Kreymerman P
Furne C
Madeuf E
Höennscheidt C
Mraz Robinson D
author_sort Danysz W
title Can Sodium Thiosulfate Act as a Reversal Agent for Calcium Hydroxylapatite Filler? Results of a Preclinical Study
title_short Can Sodium Thiosulfate Act as a Reversal Agent for Calcium Hydroxylapatite Filler? Results of a Preclinical Study
title_full Can Sodium Thiosulfate Act as a Reversal Agent for Calcium Hydroxylapatite Filler? Results of a Preclinical Study
title_fullStr Can Sodium Thiosulfate Act as a Reversal Agent for Calcium Hydroxylapatite Filler? Results of a Preclinical Study
title_full_unstemmed Can Sodium Thiosulfate Act as a Reversal Agent for Calcium Hydroxylapatite Filler? Results of a Preclinical Study
title_sort can sodium thiosulfate act as a reversal agent for calcium hydroxylapatite filler? results of a preclinical study
publisher Dove Medical Press
series Clinical, Cosmetic and Investigational Dermatology
issn 1178-7015
publishDate 2020-12-01
description Wojciech Danysz,1 Bartosch Nowag,1 Thomas Hengl,1 Peter Kreymerman,2 Céline Furne,3 Elise Madeuf,4 Christoph Höennscheidt,1 Deanne Mraz Robinson5,6 1R&D, Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany; 2Medical Affairs, Merz North America, Raleigh, NC, USA; 3NAMSA, Chasse sur Rhône, France; 4Preclinical Studies, Voxcan, Marcy L´Etoile, France; 5Modern Dermatology of Connecticut, Westport, CT, USA; 6Yale-New Haven Hospital, New Haven, CT, USACorrespondence: Wojciech DanyszMerz Pharmaceuticals GmbH, Eckenheimer Landstrasse 100, Frankfurt am Main 60318, GermanyEmail Wojciech.danysz@merz.deIntroduction: Calcium hydroxylapatite microspheres suspended in a gel carrier of sodium carboxymethylcellulose (CaHA; Radiesse®) has demonstrated safe and effective restoration of facial volume in clinical trials, as well as collagen biostimulation leading to skin quality improvement. The potential with CaHA, as with any filler, to produce overcorrection and subsequent complications has led to the search for a reversal agent. Sodium thiosulfate (STS) was proposed based on experience with it as a chelating agent to treat calciphylaxis. Previous pilot studies with small sample sizes have suggested its efficacy in the reduction of CaHA volume and nodule formation. The present study focuses on the verification of this effect using various readout methods in preclinical experiments.Methods: We use both in vitro (co-incubation of STS with CaHA) and in vivo (injections in farm pig) methods with readout techniques such as 3D camera analysis, micro-computed tomography ex vivo (μCT), computed tomography in vivo (CT), histopathology and scanning electron microscopy.Results: We did not obtain any indications of CaHA degradation by STS, either in vitro or in vivo. 3D-camera analysis also did not show any decreasing effect of STS on CaHA. However, histology, μCT ex vivo, and CT in vivo indicated a decrease of Radiesse amount/volume after STS treatment, which could be attributed to dispersion effect. It should be noted that necrosis and haemorrhages were observed after STS treatment.Discussion: Results suggest no indication of CaHA microspheres degradation with STS and that the STS mechanism of action on CaHA is consistent with a dispersion effect. Observed necrosis is a further obstacle in the use of STS.Keywords: calcium hydroxylapatite, sodium thiosulfate, dispersion effect, computed tomography, histology, 3D camera
topic calcium hydroxylapatite
sodium thiosulfate
dispersion effect
computer tomography
histology
3d camera
url https://www.dovepress.com/can-sodium-thiosulfate-act-as-a-reversal-agent-for-calcium-hydroxylapa-peer-reviewed-article-CCID
work_keys_str_mv AT danyszw cansodiumthiosulfateactasareversalagentforcalciumhydroxylapatitefillerresultsofapreclinicalstudy
AT nowagb cansodiumthiosulfateactasareversalagentforcalciumhydroxylapatitefillerresultsofapreclinicalstudy
AT henglt cansodiumthiosulfateactasareversalagentforcalciumhydroxylapatitefillerresultsofapreclinicalstudy
AT kreymermanp cansodiumthiosulfateactasareversalagentforcalciumhydroxylapatitefillerresultsofapreclinicalstudy
AT furnec cansodiumthiosulfateactasareversalagentforcalciumhydroxylapatitefillerresultsofapreclinicalstudy
AT madeufe cansodiumthiosulfateactasareversalagentforcalciumhydroxylapatitefillerresultsofapreclinicalstudy
AT hoennscheidtc cansodiumthiosulfateactasareversalagentforcalciumhydroxylapatitefillerresultsofapreclinicalstudy
AT mrazrobinsond cansodiumthiosulfateactasareversalagentforcalciumhydroxylapatitefillerresultsofapreclinicalstudy
_version_ 1724347782369640448